search
Back to results

Use of 48 Hour Course of Antibiotics to Prevent Surgical Site Infection in Obese Patients Undergoing Cesarean Delivery (SSI)

Primary Purpose

Surgical Site Infection in Obese Women Undergoing C-section

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
cephalexin & metronidazole
placebo
Sponsored by
University of Cincinnati
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Surgical Site Infection in Obese Women Undergoing C-section focused on measuring surgical site infection, obesity, pregnancy, cesarean section, cesarean delivery

Eligibility Criteria

13 Years - undefined (Child, Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • BMI > 30kg/m*2
  • Delivery via cesarean section
  • consent to participate
  • age 13 or older

Exclusion Criteria:

  • known immunodeficiency syndromes
  • non-English speaking
  • known allergy to cephalosporins or metronidazole

Sites / Locations

  • The Univeristy Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Cephalexin and metronidazole

Placebo/standard of care

Arm Description

500 mg cephalexin per oral every 8 hours for total of 6 doses; 500 mg metronidazole per oral every 8 hours for total of 6 doses

Placebo pills per oral every 8 hours for total of 6 doses

Outcomes

Primary Outcome Measures

Surgical site infection

Secondary Outcome Measures

Febrile morbidity; Urinary tract infection; Endometritis

Full Information

First Posted
September 1, 2010
Last Updated
November 10, 2011
Sponsor
University of Cincinnati
search

1. Study Identification

Unique Protocol Identification Number
NCT01194115
Brief Title
Use of 48 Hour Course of Antibiotics to Prevent Surgical Site Infection in Obese Patients Undergoing Cesarean Delivery
Acronym
SSI
Official Title
Use of 48 Hour Course of Antibiotics to Prevent Surgical Site Infection in Obese Patients Undergoing Cesarean Delivery
Study Type
Interventional

2. Study Status

Record Verification Date
November 2011
Overall Recruitment Status
Unknown status
Study Start Date
September 2010 (undefined)
Primary Completion Date
September 2012 (Anticipated)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Cincinnati

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate if preoperative antibiotics, followed by 48 hour course of broad spectrum antibiotics prevents wound infection complications in patients that are obese who undergo cesarean section. Standard antibiotic prophylaxis in all weight women undergoing cesarean section is cefazolin prior to skin incision. It is the hypothesis that a prolonged, 48 hour course of broad spectrum antibiotics that are suited to prevent growth of normal vaginal flora will decrease the rate of surgical site infection in obese patients that are at a greatly increased risk of postoperative infections complications.
Detailed Description
We propose the conduction of a prospective, randomized, double-blinded clinical trial to evaluate an alternative prophylactic regimen for the prevention of surgical site infection. This study is to be conducted by the Department of Obstetrics at University Hospital. The intervention being studied will be the continuation of cephalexin and metronidazole for 48 hours. The primary outcome measure will be the development of infectious morbidity, including wound infection and endometritis, in the postoperative period. In order to most effectively and accurately analyze our primary and secondary research outcomes, the investigators will standardize our surgical operation techniques in all ways feasible. These recommendations will be in concordance with American College of Obstetrics and Gynecology recommendations, as those generally accepted in the medical literature. All patients will undergo surgery in the same small group of HEPA filtration and positive air pressure operating rooms. Appropriate limitations on number of surgeons and assistants scrubbed for surgery as well as general OR traffic will be enforced. Patients will undergo hair clipping of the incision site when appropriate. Chlorhexidine skin decontamination will be the standard surgical site preparation. An antimicrobial, adhesive drape will be used. Prior to skin incision, cefazolin will be administered. All patients to be considered for recruitment to this study will be undergoing delivery at University Hospital. Patients with an elevated BMI > 30 kg/m2 who undergo cesarean section will be considered for randomization either prior to delivery or in the first 7 hours after delivery, to accommodate the need for the first dose of study medication or placebo 8 hours after surgery. Only patients who agree to inclusion after informed consent will be randomized per protocol.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Surgical Site Infection in Obese Women Undergoing C-section
Keywords
surgical site infection, obesity, pregnancy, cesarean section, cesarean delivery

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
475 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cephalexin and metronidazole
Arm Type
Experimental
Arm Description
500 mg cephalexin per oral every 8 hours for total of 6 doses; 500 mg metronidazole per oral every 8 hours for total of 6 doses
Arm Title
Placebo/standard of care
Arm Type
Placebo Comparator
Arm Description
Placebo pills per oral every 8 hours for total of 6 doses
Intervention Type
Drug
Intervention Name(s)
cephalexin & metronidazole
Other Intervention Name(s)
Keflex & Flagyl
Intervention Description
cephalexin at 500 mg per oral every 8 hours for a total of 6 doses
Intervention Type
Drug
Intervention Name(s)
placebo
Intervention Description
placebo representing standard of care
Primary Outcome Measure Information:
Title
Surgical site infection
Time Frame
6weeks post partum
Secondary Outcome Measure Information:
Title
Febrile morbidity; Urinary tract infection; Endometritis
Time Frame
6 weeks post partum

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
13 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: BMI > 30kg/m*2 Delivery via cesarean section consent to participate age 13 or older Exclusion Criteria: known immunodeficiency syndromes non-English speaking known allergy to cephalosporins or metronidazole
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carri Warshak, MD
Organizational Affiliation
University of Cincinnati
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Univeristy Hospital
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45219
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
20091509
Citation
Hofmeyr GJ, Smaill FM. WITHDRAWAN. Antibiotic prophylaxis for cesarean section. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000933. doi: 10.1002/14651858.CD000933.pub2.
Results Reference
background
PubMed Identifier
14570343
Citation
Meyer NL, Hosier KV, Scott K, Lipscomb GH. Cefazolin versus cefazolin plus metronidazole for antibiotic prophylaxis at cesarean section. South Med J. 2003 Oct;96(10):992-5. doi: 10.1097/01.SMJ.0000060570.51934.14.
Results Reference
background
PubMed Identifier
16319263
Citation
Robinson HE, O'Connell CM, Joseph KS, McLeod NL. Maternal outcomes in pregnancies complicated by obesity. Obstet Gynecol. 2005 Dec;106(6):1357-64. doi: 10.1097/01.AOG.0000188387.88032.41.
Results Reference
background
PubMed Identifier
6535654
Citation
Elyan A, Mahran M, el-Maraghy M, Abou-Seeda M. Prophylactic intravenous metronidazole in cesarean section. Chemioterapia. 1984 Feb;3(1):67-70.
Results Reference
background
PubMed Identifier
18771992
Citation
Tita AT, Owen J, Stamm AM, Grimes A, Hauth JC, Andrews WW. Impact of extended-spectrum antibiotic prophylaxis on incidence of postcesarean surgical wound infection. Am J Obstet Gynecol. 2008 Sep;199(3):303.e1-3. doi: 10.1016/j.ajog.2008.06.068.
Results Reference
background
PubMed Identifier
28975304
Citation
Valent AM, DeArmond C, Houston JM, Reddy S, Masters HR, Gold A, Boldt M, DeFranco E, Evans AT, Warshak CR. Effect of Post-Cesarean Delivery Oral Cephalexin and Metronidazole on Surgical Site Infection Among Obese Women: A Randomized Clinical Trial. JAMA. 2017 Sep 19;318(11):1026-1034. doi: 10.1001/jama.2017.10567. Erratum In: JAMA. 2017 Nov 14;318(18):1832.
Results Reference
derived

Learn more about this trial

Use of 48 Hour Course of Antibiotics to Prevent Surgical Site Infection in Obese Patients Undergoing Cesarean Delivery

We'll reach out to this number within 24 hrs